Christoph J Auernhammer

Christoph J Auernhammer

UNVERIFIED PROFILE

Are you Christoph J Auernhammer?   Register this Author

Register author
Christoph J Auernhammer

Christoph J Auernhammer

Publications by authors named "Christoph J Auernhammer"

Are you Christoph J Auernhammer?   Register this Author

59Publications

948Reads

46Profile Views

Multiband mucosectomy versus endoscopic submucosal dissection and endoscopic submucosal excavation for GI submucosal tumors: short and long term follow-up.

BMC Cancer 2019 Sep 6;19(1):893. Epub 2019 Sep 6.

Department of Internal Medicine 4, University-Hospital Campus Grosshadern, Ludwig-Maximilians-University of Munich, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-019-6100-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6731551PMC
September 2019

Immune checkpoint markers in gastroenteropancreatic neuroendocrine neoplasia.

Endocr Relat Cancer 2019 03;26(3):293-301

Interdisciplinary Center of Neuroendocrine Tumors of the GastroEnteroPancreatic System, Ludwig-Maximilians-University of Munich, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1530/ERC-18-0494DOI Listing
March 2019

Supportive therapy in gastroenteropancreatic neuroendocrine tumors: Often forgotten but important.

Rev Endocr Metab Disord 2018 06;19(2):145-158

Department of Internal Medicine IV, University-Hospital Campus Grosshadern, Ludwig-Maximilian University of Munich, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11154-018-9443-6DOI Listing
June 2018

Advanced neuroendocrine tumours of the small intestine and pancreas: clinical developments, controversies, and future strategies.

Lancet Diabetes Endocrinol 2018 05 8;6(5):404-415. Epub 2017 Dec 8.

Interdisciplinary Center of Neuroendocrine Tumours of the GastroEnteroPancreatic System, Ludwig-Maximilians-University of Munich, Munich, Germany; Department of Nuclear Medicine, Ludwig-Maximilians-University of Munich, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2213-8587(17)30401-1DOI Listing
May 2018

Tropomyosin receptor kinase: a novel target in screened neuroendocrine tumors.

Endocr Relat Cancer 2018 05 21;25(5):547-560. Epub 2018 Mar 21.

Interdisciplinary Center of Neuroendocrine Tumors of the GastroEnteroPancreatic System (GEPNET-KUM), Klinikum der Universität München, Ludwig-Maximilians-University of Munich, Campus Grosshadern, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1530/ERC-17-0201DOI Listing
May 2018

Towards new response criteria in neuroendocrine tumors: which changes in MRI parameters are associated with longer progression-free survival after radioembolization of liver metastases?

J Magn Reson Imaging 2015 Feb 21;41(2):361-8. Epub 2014 Jan 21.

Department of Clinical Radiology, University Hospitals-Grosshadern, Ludwig-Maximilians University, Munich, Germany; Interdisciplinary Center of Neuroendocrine Tumours of the GastroEnteroPancreatic System (GEPNET-KUM), University Hospitals-Grosshadern, Ludwig-Maximilians University, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jmri.24569DOI Listing
February 2015

[Advanced radioiodine-refractory differentiated thyroid cancer].

Dtsch Med Wochenschr 2015 Feb 6;140(3):168-71. Epub 2015 Feb 6.

Medizinische Klinik und Poliklinik II, Klinikum der Universität München.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0041-100196DOI Listing
February 2015

Impact of (68)Ga-DOTATATE PET/CT on the surgical management of primary neuroendocrine tumors of the pancreas or ileum.

Ann Surg Oncol 2015 Jan 5;22(1):164-71. Epub 2014 Sep 5.

Department of Nuclear Medicine, Ludwig-Maximilians-University of Munich, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-014-3981-2DOI Listing
January 2015

Diagnostic accuracy of dynamic gadoxetic-acid-enhanced MRI and PET/CT compared in patients with liver metastases from neuroendocrine neoplasms.

J Magn Reson Imaging 2014 Aug 18;40(2):457-66. Epub 2013 Dec 18.

Department of Clinical Radiology, University Hospitals-Grosshadern, Ludwig-Maximilians University, Munich, Germany.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/jmri.24363
Publisher Site
http://dx.doi.org/10.1002/jmri.24363DOI Listing
August 2014

Aspirin inhibits cell viability and mTOR downstream signaling in gastroenteropancreatic and bronchopulmonary neuroendocrine tumor cells.

World J Gastroenterol 2014 Aug;20(29):10038-49

Matilde Spampatti, George Vlotides, Gerald Spöttl, Julian Maurer, Burkhard Göke, Christoph J Auernhammer, Department of Internal Medicine II, University-Hospital Campus Grosshadern, Interdisciplinary Center of Neuroendocrine Tumours of the GastroEnteroPancreatic System (GEPNET-KUM), Ludwig-Maximilians-University of Munich, 81377 Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3748/wjg.v20.i29.10038DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4123333PMC
August 2014

The novel somatostatin receptor 2/dopamine type 2 receptor chimeric compound BIM-23A758 decreases the viability of human GOT1 midgut carcinoid cells.

Neuroendocrinology 2013 31;98(2):128-36. Epub 2013 Jul 31.

Department of Internal Medicine II, University Hospital Campus Grosshadern, Ludwig Maximilians University, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000353784DOI Listing
July 2014

Neuroendocrine tumor recurrence: diagnosis with 68Ga-DOTATATE PET/CT.

Radiology 2014 Feb 28;270(2):517-25. Epub 2013 Oct 28.

From the Department of Nuclear Medicine (A.R.H., R.C., B.W., C.U., P.B., M.H.), Interdisciplinary Center of Neuroendocrine Tumors of the Gastro-Entero-Pancreatic System (A.R.H., C.J.A., C.S., P.B.), Department of Internal Medicine 2 (C.J.A., C.S.), Medizinische Klinik und Poliklinik 4 (M.R., F.B.), and Institute of Clinical Radiology (G.P.S.), Klinikum Grosshadern, Ludwig-Maximilians-University of Munich, Marchioninistrasse 15, Munich 81377, Germany; and Department of Nuclear Medicine, Medical University of Vienna, Vienna, Austria (M.H.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiol.13122501DOI Listing
February 2014

Evaluation of neuroendocrine liver metastases: a comparison of dynamic contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography.

Invest Radiol 2014 Jan;49(1):7-14

From the *Department of Clinical Radiology, University Hospitals-Grosshadern, Ludwig Maximilians University, Munich, Germany; †Division of Medical Physics, University of Leeds, Leeds, United Kingdom; ‡Department of Nuclear Medicine, University Hospitals-Grosshadern, Ludwig Maximilians University, Munich, Germany; §Department of Clinical Radiology, University of Basel, Basel, Switzerland; and ¶Department of Internal Medicine II, Campus Grosshadern, Interdisciplinary Center of Neuroendocrine Tumors of the GastroEnteroPancreatic System, University Hospitals-Grosshadern, Ludwig Maximilians University, Munich, Germany.

View Article

Download full-text PDF

Source
http://clinical-mri.com/wp-content/uploads/2014/01/Evaluatio
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/RLI.0b013e3182a4eb4aDOI Listing
January 2014

Potent antitumor activity of the novel HSP90 inhibitors AUY922 and HSP990 in neuroendocrine carcinoid cells.

Int J Oncol 2013 Dec 4;43(6):1824-32. Epub 2013 Oct 4.

Department of Internal Medicine II Campus Grosshadern, University-Hospital, Ludwig-Maximilians-University of Munich, D‑81377 Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ijo.2013.2130DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3834873PMC
December 2013

Defining predictors for long progression-free survival after radioembolisation of hepatic metastases of neuroendocrine origin.

Eur Radiol 2013 Nov 28;23(11):3094-103. Epub 2013 Jun 28.

Department of Clinical Radiology, University Hospitals-Grosshadern, Ludwig-Maximilians University, Munich, Germany,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00330-013-2925-8DOI Listing
November 2013

Fluid-fluid level in hepatic metastases: a characteristic sign of metastases of neuroendocrine origin.

Eur J Radiol 2012 Sep 5;81(9):2127-32. Epub 2011 Oct 5.

Department of Clinical Radiology, University Hospitals-Grosshadern, Ludwig-Maximilians University, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejrad.2011.09.012DOI Listing
September 2012

Perifosine-mediated Akt inhibition in neuroendocrine tumor cells: role of specific Akt isoforms.

Endocr Relat Cancer 2012 Jun 24;19(3):423-34. Epub 2012 May 24.

Department of Internal Medicine II, University-Hospital Munich-Grosshadern, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1530/ERC-12-0074DOI Listing
June 2012

Chromogranin a as serum marker for gastroenteropancreatic neuroendocrine tumors: a single center experience and literature review.

Cancers (Basel) 2012 Feb 15;4(1):141-55. Epub 2012 Feb 15.

Department of Internal Medicine II, Campus Grosshadern, University-Hospital of the Ludwig-Maximilians-University of Munich, Munich 81377, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers4010141DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3712684PMC
February 2012

Contrast-enhanced ultrasound for surveillance of choroidal carcinoma patients: features of liver metastasis arising several years after treatment of the primary tumor.

Case Rep Oncol 2011 9;4(2):336-42. Epub 2011 Jul 9.

Department of Internal Medicine, University Hospital of the University of Munich, Campus Grosshadern, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000329453DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3134033PMC
November 2011

Therapeutic strategies for advanced neuroendocrine carcinomas of jejunum/ileum and pancreatic origin.

Gut 2011 Jul 4;60(7):1009-21. Epub 2011 Mar 4.

Department of Internal Medicine II, University-Hospital Campus Grosshadern, Interdisciplinary Center of Neuroendocrine Tumours of the GastroEnteroPancreatic System (GEPNET-KUM), Ludwig-Maximilians-University of Munich, Munich 81377, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/gut.2009.204453DOI Listing
July 2011

The novel Raf inhibitor Raf265 decreases Bcl-2 levels and confers TRAIL-sensitivity to neuroendocrine tumour cells.

Endocr Relat Cancer 2011 Apr 21;18(2):277-85. Epub 2011 Mar 21.

Department of Internal Medicine II, University-Hospital Munich-Grosshadern, University of Munich, Marchioninistr.15, 81377 Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1530/ERC-10-0108DOI Listing
April 2011

Compensatory activation of Akt in response to mTOR and Raf inhibitors - a rationale for dual-targeted therapy approaches in neuroendocrine tumor disease.

Cancer Lett 2010 Sep 30;295(1):100-9. Epub 2010 Mar 30.

Department of Internal Medicine II, University-Hospital Munich-Grosshadern, University of Munich, Marchioninistr.15, 81377 Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2010.02.018DOI Listing
September 2010

Bone morphogenetic proteins 2 and 5 are down-regulated in adrenocortical carcinoma and modulate adrenal cell proliferation and steroidogenesis.

Cancer Res 2009 Jul 7;69(14):5784-92. Epub 2009 Jul 7.

Departments of Medicine, University Hospital Innenstadt, Ludwig Maximilians University, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-08-4428DOI Listing
July 2009

Intraindividual comparison of 68Ga-DOTA-TATE and 18F-DOPA PET in patients with well-differentiated metastatic neuroendocrine tumours.

Eur J Nucl Med Mol Imaging 2009 May 10;36(5):765-70. Epub 2009 Jan 10.

Department of Nuclear Medicine, Ludwig Maximilians University, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00259-008-1030-8DOI Listing
May 2009

Medical treatment of gastrinomas.

Wien Klin Wochenschr 2007 ;119(19-20):609-15

Department of Internal Medicine II, Hospital of the University of Munich, Ludwig-Maximilians-University Munich, Munich-Grosshadern, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00508-007-0877-1DOI Listing
March 2008

The role of interleukin-22 in hepatitis C virus infection.

Cytokine 2008 Mar 11;41(3):209-16. Epub 2008 Jan 11.

Department of Medicine II, University-Hospital Munich-Grosshadern, University of Munich, Marchioninistr. 15, 81377 Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cyto.2007.11.016DOI Listing
March 2008

PI(3)K-Akt-mTOR pathway as a potential therapeutic target in neuroendocrine tumors.

Expert Rev Endocrinol Metab 2008 Mar;3(2):207-222

d Department of Internal Medicine II - Grosshadern, Ludwig-Maximilians-University of Munich, Marchioninistr. 15, 81377 Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/17446651.3.2.207DOI Listing
March 2008

Anterior pituitary hormone replacement therapy--a clinical review.

Pituitary 2007 ;10(1):1-15

Department of Internal Medicine II, Klinikum der Ludwig-Maximilians-Universität München, Standort Grosshadern, Marchioninistr. 15, Munich 81377, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11102-007-0001-6DOI Listing
February 2008

Interleukin 31 mediates MAP kinase and STAT1/3 activation in intestinal epithelial cells and its expression is upregulated in inflammatory bowel disease.

Gut 2007 Sep 20;56(9):1257-65. Epub 2007 Apr 20.

University Hospital Munich-Grosshadern, Department of Medicine II, University of Munich, Marchioninistrasse 15, 81377 Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/gut.2006.118679DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1954980PMC
September 2007

The novel mTOR inhibitor RAD001 (everolimus) induces antiproliferative effects in human pancreatic neuroendocrine tumor cells.

Neuroendocrinology 2007 19;85(1):54-60. Epub 2007 Feb 19.

Department of Internal Medicine II, University Hospital Munich-Grosshadern, University of Munich, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000100057DOI Listing
June 2007

SOCS1 silencing enhances antitumor activity of type I IFNs by regulating apoptosis in neuroendocrine tumor cells.

Cancer Res 2007 May;67(10):5025-32

Department of Internal Medicine II, University-Hospital Munich-Grosshadern, University of Munich, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-06-2575DOI Listing
May 2007

IL-22-mediated liver cell regeneration is abrogated by SOCS-1/3 overexpression in vitro.

Am J Physiol Gastrointest Liver Physiol 2007 Apr 4;292(4):G1019-28. Epub 2007 Jan 4.

Department of Medicine II, University-Hospital Munich-Grosshadern and University of Munich, Marchioninistrasse 15, 81377 Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1152/ajpgi.00239.2006DOI Listing
April 2007

Novel interferon-lambdas induce antiproliferative effects in neuroendocrine tumor cells.

Biochem Biophys Res Commun 2006 Jun 24;344(4):1334-41. Epub 2006 Apr 24.

Department of Internal Medicine II, University-Hospital Munich-Grosshadern, University of Munich, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbrc.2006.04.043DOI Listing
June 2006

IL-28A and IL-29 mediate antiproliferative and antiviral signals in intestinal epithelial cells and murine CMV infection increases colonic IL-28A expression.

Am J Physiol Gastrointest Liver Physiol 2005 Nov 28;289(5):G960-8. Epub 2005 Jul 28.

Department of Medicine II, University-Hospital Munich-Grosshadern, University of Munich, D-81377 Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1152/ajpgi.00126.2005DOI Listing
November 2005

Role of the intracellular receptor domain of gp130 (exon 17) in human inflammatory bowel disease.

World J Gastroenterol 2005 Feb;11(8):1196-9

Department of Internal Medicine II, Klinikum Grosshadern, Ludwig-Maximilians-University, Marchioninistr 15, D-81377 Munich, Germany.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4250713PMC
http://dx.doi.org/10.3748/wjg.v11.i8.1196DOI Listing
February 2005

Novel neurotrophin-1/B cell-stimulating factor-3 (NNT-1/BSF-3)/cardiotrophin-like cytokine (CLC)--a novel gp130 cytokine with pleiotropic functions.

Cytokine Growth Factor Rev 2004 Oct;15(5):325-36

Department of Internal Medicine II, Klinikum der Ludwig-Maximilians-Universität München, Standort Grosshadern, Marchioninistr 15, Munich 81377, Germany.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S135961010400040
Publisher Site
http://dx.doi.org/10.1016/j.cytogfr.2004.04.002DOI Listing
October 2004

SOCS-1 and SOCS-3 inhibit IFN-alpha-induced expression of the antiviral proteins 2,5-OAS and MxA.

Biochem Biophys Res Commun 2004 Jul;320(3):1007-14

Department of Internal Medicine II, Grosshadern, Klinikum der Ludwig, Maximilians-Universität, Munich 81377, Germany.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S0006291X0401332
Publisher Site
http://dx.doi.org/10.1016/j.bbrc.2004.06.051DOI Listing
July 2004

The oncostatin M receptor/gp130 ligand murine oncostatin M induces apoptosis in adrenocortical Y-1 tumor cells.

J Endocrinol 2004 Mar;180(3):479-86

Department of Internal Medicine II, Klinikum Grosshadern, Ludwig-Maximilians-Universität, Marchioninistr. 15, Munich 81377, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1677/joe.0.1800479DOI Listing
March 2004